Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: Zoonoses Public Health. 2018 Jul 19;65(7):838–849. doi: 10.1111/zph.12507

FIGURE 1.

FIGURE 1.

Ciprofloxacin nonsusceptibility and nalidixic acid resistance among nontyphoidal Salmonella surveillance isolates, United States, 1996–2014. Ciprofloxacin nonsusceptibility includes ciprofloxacin resistant (MIC ≥1 μg/mL) and intermediate (MIC 0.12–0.5 μg/mL).